Skip to main content
Premium Trial:

Request an Annual Quote

Embark Scientific Buys Mouse Genotyping Assets from MendelWorks

NEW YORK (GenomeWeb News) – Genomics services company Embark Scientific has purchased mouse genotyping assets from MendelWorks, an Identigene spin-off, for an undisclosed sum, Embark said earlier this week.
 
Austin, Tex.-based Embark said the deal will help increase its mouse genotyping capacity and its animal genotyping market share. The added capacity includes PCR and real-time PCR-based genotyping, gene expression, and RNA expression analysis, the company said.
 
In addition to mouse genotyping, Embark offers DNA sequencing, RNA expression analysis, assay development, and lab consulting services to clients in government, academia, and in industry.
 
Financial terms of the agreement were not released.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.